Epinephrine Market By Type (Epinephrine Prefilled Syringe, Combination Epinephrine Products and Epinephrine Auto-injector) and Application (Cardiac Arrest, Anaphylaxis and Others) - Global Industry Analysis And Forecast To 2027
Published On : August 2018 Pages : 180 Category: Healthcare IT Report Code : HC081204
Industry Outlook
Epinephrine is also referred to as adrenalin or adrenaline, which is a medication and hormone. It finds application is medication of different disorders like; cardiac arrest, superficial bleeding and anaphylaxis. Used for the treatment of asthma when other therapies are not working. Epinephrine can be given to patient by injecting in muscles or under the skin and through inhalation. Epinephrine is created in the body by adrenal gland and also some neurons. It acts in significant tasks like; working of heart, maximizing flow of blood to muscles, blood sugar and pupil dilation. Epinephrine is seen in one cell organisms and number of animals. Therefore, the Epinephrine Market is anticipated to expand and has tremendous scope during the forecast period. The global Epinephrine Market is anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global Epinephrine Market is based on segment; by Type the market is segmented into Epinephrine Prefilled Syringe, Combination Epinephrine Products and Epinephrine Auto-injector; and by Application the market is segmented into Cardiac Arrest, Anaphylaxis and Others.
- Epinephrine Market, By Type
- Epinephrine Prefilled Syringe
- Combination Epinephrine Products
- Epinephrine Auto-injector
- Epinephrine Market, By Application
- Cardiac Arrest
- Anaphylaxis
- Others
Regional Insights
On a global front, the Epinephrine Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).
Epinephrine Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Pfizer, Grand Pharma, Harvest Pharmaceuticals, Mylan Inc., ALK Abello, Tianjin Jinyao Group, Amphastar, Impax, Emerade, Lincoln Medical Ltd and Merit Pharmaceutical. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Pfizer
- Grand Pharma
- Harvest Pharmaceuticals
- Mylan Inc
- ALK Abello
- Tianjin Jinyao Group
- Amphastar
- Impax
- Emerade
- Lincoln Medical Ltd
- Merit Pharmaceutical
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Epinephrine Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Epinephrine Prefilled Syringe
o Combination Epinephrine Products
o Epinephrine Auto-injector
o Epinephrine Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Cardiac Arrest
o Anaphylaxis
o Others
Epinephrine Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Epinephrine Market, By Country
o U.S. Epinephrine Market
o Canada Epinephrine Market
o Mexico Epinephrine Market
o Europe
§ Europe Epinephrine Market, By Country
o Germany Epinephrine Market
o UK Epinephrine Market
o France Epinephrine Market
o Russia Epinephrine Market
o Italy Epinephrine Market
o Rest of Europe Epinephrine Market
o Asia-Pacific
§ Asia-Pacific Epinephrine Market, By Country
o China Epinephrine Market
o Japan Epinephrine Market
o South Korea Epinephrine Market
o India Epinephrine Market
o Southeast Asia Epinephrine Market
o Rest of Asia-Pacific Epinephrine Market
o South America
§ South America Epinephrine Market, By Country
o Brazil Epinephrine Market
o Argentina Epinephrine Market
o Columbia Epinephrine Market
o Rest of South America Epinephrine Market
o Middle East and Africa
§ Middle East and Africa Epinephrine Market, By Country
o Saudi Arabia Epinephrine Market
o UAE Epinephrine Market
o Egypt Epinephrine Market
o Nigeria Epinephrine Market
o South Africa Epinephrine Market
o Rest of MEA Epinephrine Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2027)
4.1.2. Canada Market States and Outlook (2017-2027)
4.1.3. Mexico Market States and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2027)
4.2.2. France Market States and Outlook (2017-2027)
4.2.3. UK Market States and Outlook (2017-2027)
4.2.4. Russia Market States and Outlook (2017-2027)
4.2.5. Italy Market States and Outlook (2017-2027)
4.2.6. Rest of Europe Market States and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2027)
4.3.2. Japan Market States and Outlook (2017-2027)
4.3.3. Korea Market States and Outlook (2017-2027)
4.3.4. India Market States and Outlook (2017-2027)
4.3.5. Southeast Asia Market States and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market States and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2027)
4.4.2. Argentina Market States and Outlook (2017-2027)
4.4.3. Columbia Market States and Outlook (2017-2027)
4.4.4. Rest of South America Market States and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2027)
4.5.2. United Arab Emirates Market States and Outlook (2017-2027)
4.5.3. Egypt Market States and Outlook (2017-2027)
4.5.4. Nigeria Market States and Outlook (2017-2027)
4.5.5. South Africa Market States and Outlook (2017-2027)
4.5.6. Turkey Market States and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market States and Outlook (2017-2027)
5. Epinephrine Market, By Type
5.1. Introduction
5.2. Global Epinephrine Revenue and Market Share by Type (2017-2027)
5.2.1. Global Epinephrine Revenue and Revenue Share by Type (2017-2027)
5.3. Epinephrine Prefilled Syringe
5.3.1. Global Epinephrine Prefilled Syringe Revenue and Growth Rate (2017-2027)
5.4. Combination Epinephrine Products
5.4.1. Global Combination Epinephrine Products Revenue and Growth Rate (2017-2027)
5.5. Epinephrine Auto-injector
5.5.1. Global Epinephrine Auto-injector Revenue and Growth Rate (2017-2027)
6. Epinephrine Market, By Application
6.1. Introduction
6.2. Global Epinephrine Revenue and Market Share by Application (2017-2027)
6.2.1. Global Epinephrine Revenue and Revenue Share by Application (2017-2027)
6.3. Cardiac Arrest
6.3.1. Global Cardiac Arrest Revenue and Growth Rate (2017-2027)
6.4. Anaphylaxis
6.4.1. Global Anaphylaxis Revenue and Growth Rate (2017-2027)
6.5. Others
6.5.1. Global Others Revenue and Growth Rate (2017-2027)
7. Epinephrine Market, By Region
7.1. Introduction
7.2. Global Epinephrine Revenue and Market Share by Regions
7.2.1. Global Epinephrine Revenue by Regions (2017-2027)
7.3. North America Epinephrine by Countries
7.3.1. North America Epinephrine Revenue and Growth Rate (2017-2027)
7.3.2. North America Epinephrine Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Epinephrine by Countries
7.4.1. Europe Epinephrine Revenue and Growth Rate (2017-2027)
7.4.2. Europe Epinephrine Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Epinephrine by Countries
7.5.1. Asia-Pacific Epinephrine Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Epinephrine Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Epinephrine by Countries
7.6.1. South America Epinephrine Revenue and Growth Rate (2017-2027)
7.6.2. South America Epinephrine Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Epinephrine by Countries
7.7.1. Middle East and Africa Epinephrine Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Epinephrine Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Pfizer
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Revenue and Market Share
8.2. Grand Pharma
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Revenue and Market Share
8.3. Harvest Pharmaceuticals
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Revenue and Market Share
8.4. Mylan Inc
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Revenue and Market Share
8.5. ALK Abello
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Revenue and Market Share
8.6. Tianjin Jinyao Group
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Revenue and Market Share
8.7. Amphastar
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Revenue and Market Share
8.8. Impax
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Revenue and Market Share
8.9. Emerade
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Revenue and Market Share
8.10. Lincoln Medical Ltd
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Revenue and Market Share
8.11. Merit Pharmaceutical
8.11.1. Business Overview
8.11.2. Service Portfolio
8.11.3. Strategic Developments
8.11.4. Revenue and Market Share
9. Global Epinephrine Market Competition, by Manufacturer
9.1. Global Epinephrine Revenue and Market Share by Manufacturer (2017-2017)
9.2. Global Epinephrine Price By Region (2017-2017)
9.3. Top 5 Epinephrine Manufacturer Market Share
9.4. Market Competition Trend
10. Epinephrine Market Forecast (2017-2027)
10.1. Global Epinephrine Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Epinephrine Market Forecast by Regions (2017-2027)
10.2.1. North America Epinephrine Market Forecast (2017-2027)
10.2.1.1. United States Epinephrine Market Forecast (2017-2027)
10.2.1.2. Canada Epinephrine Market Forecast (2017-2027)
10.2.1.3. Mexico Epinephrine Market Forecast (2017-2027)
10.2.2. Europe Epinephrine Market Forecast (2017-2027)
10.2.2.1. Germany Epinephrine Market Forecast (2017-2027)
10.2.2.2. France Epinephrine Market Forecast (2017-2027)
10.2.2.3. UK Epinephrine Market Forecast (2017-2027)
10.2.2.4. Russia Epinephrine Market Forecast (2017-2027)
10.2.2.5. Italy Epinephrine Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Epinephrine Market Forecast (2017-2027)
10.2.3. Asia-Pacific Epinephrine Market Forecast (2017-2027)
10.2.3.1. China Epinephrine Market Forecast (2017-2027)
10.2.3.2. Japan Epinephrine Market Forecast (2017-2027)
10.2.3.3. Korea Epinephrine Market Forecast (2017-2027)
10.2.3.4. India Epinephrine Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Epinephrine Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Epinephrine Market Forecast (2017-2027)
10.2.4. South America Epinephrine Market Forecast (2017-2027)
10.2.4.1. Brazil Epinephrine Market Forecast (2017-2027)
10.2.4.2. Argentina Epinephrine Market Forecast (2017-2027)
10.2.4.3. Columbia Epinephrine Market Forecast (2017-2027)
10.2.4.4. Rest of South America Epinephrine Market Forecast (2017-2027)
10.2.5. Middle East and Africa Epinephrine Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Epinephrine Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Epinephrine Market Forecast (2017-2027)
10.2.5.3. Egypt Epinephrine Market Forecast (2017-2027)
10.2.5.4. Nigeria Epinephrine Market Forecast (2017-2027)
10.2.5.5. South Africa Epinephrine Market Forecast (2017-2027)
10.2.5.6. Turkey Epinephrine Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Epinephrine Market Forecast (2017-2027)
10.3. Epinephrine Market Forecast by Type (2017-2027)
10.3.1. Epinephrine Forecast by Type (2017-2027)
10.3.2. Epinephrine Market Share Forecast by Type (2017-2027)
10.4. Epinephrine Market Forecast by Application (2017-2027)
10.4.1. Epinephrine Forecast by Application (2017-2027)
Epinephrine Market Share Forecast by Application (2017-2027)
List of Tables
11. List of Tables and Figures
Figure United States Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Epinephrine Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Epinephrine Revenue and Revenue Share by Type (2017-2018)
Figure Global Epinephrine Prefilled Syringe Revenue and Growth Rate (2017-2018)
Figure Global Combination Epinephrine Products Revenue and Growth Rate (2017-2018)
Figure Global Epinephrine Auto-injector Revenue and Growth Rate (2017-2018)
Table Global Epinephrine Revenue and Revenue Share by Application (2017-2018)
Figure Global Cardiac Arrest Revenue and Growth Rate (2017-2018)
Figure Global Anaphylaxis Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Epinephrine Revenue by Regions (2017-2018)
Figure North America Epinephrine Growth Rate (2017-2018)
Figure North America Epinephrine Revenue and Growth Rate (2017-2018)
Figure North America Epinephrine by Countries (2017-2018)
Figure North America Epinephrine Revenue (Million USD) by Countries (2017-2018)
Figure United States Epinephrine Growth Rate (2017-2018)
Figure United States Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Epinephrine Growth Rate (2017-2018)
Figure Canada Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Epinephrine Growth Rate (2017-2018)
Figure Mexico Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Epinephrine Growth Rate (2017-2018)
Figure Europe Epinephrine Revenue and Growth Rate (2017-2018)
Figure Europe Epinephrine by Countries (2017-2018)
Figure Europe Epinephrine Revenue (Million USD) by Countries (2017-2018)
Figure Germany Epinephrine Growth Rate (2017-2018)
Figure Germany Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Epinephrine Growth Rate (2017-2018)
Figure France Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Epinephrine Growth Rate (2017-2018)
Figure UK Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Epinephrine Growth Rate (2017-2018)
Figure Russia Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Epinephrine Growth Rate (2017-2018)
Figure Italy Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Epinephrine Growth Rate (2017-2018)
Figure Rest of Europe Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Epinephrine Growth Rate (2017-2018)
Figure Asia-Pacific Epinephrine Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Epinephrine by Countries (2017-2018)
Figure Asia-Pacific Epinephrine Revenue (Million USD) by Countries (2017-2018)
Figure China Epinephrine Growth Rate (2017-2018)
Figure China Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Epinephrine Growth Rate (2017-2018)
Figure Japan Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Epinephrine Growth Rate (2017-2018)
Figure Korea Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Epinephrine Growth Rate (2017-2018)
Figure India Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Epinephrine Growth Rate (2017-2018)
Figure Southeast Asia Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Epinephrine Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Epinephrine Growth Rate (2017-2018)
Figure South America Epinephrine Revenue and Growth Rate (2017-2018)
Figure South America Epinephrine by Countries (2017-2018)
Figure South America Epinephrine Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Epinephrine Growth Rate (2017-2018)
Figure Brazil Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Epinephrine Growth Rate (2017-2018)
Figure Argentina Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Epinephrine Growth Rate (2017-2018)
Figure Columbia Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Epinephrine Growth Rate (2017-2018)
Figure Rest of South America Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Epinephrine Growth Rate (2017-2018)
Figure Middle East and Africa Epinephrine Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Epinephrine by Countries (2017-2018)
Figure Middle East and Africa Epinephrine Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Epinephrine Growth Rate (2017-2018)
Figure Saudi Arabia Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Epinephrine Growth Rate (2017-2018)
Figure United Arab Emirates Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Epinephrine Growth Rate (2017-2018)
Figure Egypt Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Epinephrine Growth Rate (2017-2018)
Figure Nigeria Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Epinephrine Growth Rate (2017-2018)
Figure South Africa Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Epinephrine Growth Rate (2017-2018)
Figure Turkey Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Epinephrine Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Epinephrine Revenue (Millions USD) and Growth Rate (2017-2018)
Table Pfizer Epinephrine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Grand Pharma Epinephrine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Harvest Pharmaceuticals Epinephrine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Mylan Inc Epinephrine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ALK Abello Epinephrine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Tianjin Jinyao Group Epinephrine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Amphastar Epinephrine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Impax Epinephrine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Emerade Epinephrine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Lincoln Medical Ltd Epinephrine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merit Pharmaceutical Epinephrine Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Epinephrine Market Share by Manufacturer
Figure Global Epinephrine Revenue and Market Share by Manufacturer
Table Global Epinephrine Price by Region (2017-2017)
Figure Top 5 Epinephrine Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Epinephrine Revenue (Millions USD) and Growth Rate (2018-2025)
Table Epinephrine Market Forecast by Regions (2018-2025)
Figure North America Epinephrine Market Forecast (2018-2025)
Figure United States Epinephrine Market Forecast (2018-2025)
Figure Canada Epinephrine Market Forecast (2018-2025)
Figure Mexico Epinephrine Market Forecast (2018-2025)
Figure Europe Epinephrine Market Forecast (2018-2025)
Figure Germany Epinephrine Market Forecast (2018-2025)
Figure France Epinephrine Market Forecast (2018-2025)
Figure UK Epinephrine Market Forecast (2018-2025)
Figure Russia Epinephrine Market Forecast (2018-2025)
Figure Italy Epinephrine Market Forecast (2018-2025)
Figure Rest of Europe Epinephrine Market Forecast (2018-2025)
Figure Asia-Pacific Epinephrine Market Forecast (2018-2025)
Figure China Epinephrine Market Forecast (2018-2025)
Figure Japan Epinephrine Market Forecast (2018-2025)
Figure Korea Epinephrine Market Forecast (2018-2025)
Figure India Epinephrine Market Forecast (2018-2025)
Figure Southeast Asia Epinephrine Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Epinephrine Market Forecast (2018-2025)
Figure South America Epinephrine Market Forecast (2018-2025)
Figure Brazil Epinephrine Market Forecast (2018-2025)
Figure Argentina Epinephrine Market Forecast (2018-2025)
Figure Columbia Epinephrine Market Forecast (2018-2025)
Figure Rest of South America Epinephrine Market Forecast (2018-2025)
Figure Middle East and Africa Epinephrine Market Forecast (2018-2025)
Figure Saudi Arabia Epinephrine Market Forecast (2018-2025)
Figure United Arab Emirates Epinephrine Market Forecast (2018-2025)
Figure Egypt Epinephrine Market Forecast (2018-2025)
Figure Nigeria Epinephrine Market Forecast (2018-2025)
Figure South Africa Epinephrine Market Forecast (2018-2025)
Figure Turkey Epinephrine Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Epinephrine Market Forecast (2018-2025)
Figure Global Epinephrine Forecast by Type (2018-2025)
Figure Global Epinephrine Market Share Forecast by Type (2018-2025)
Figure Global Epinephrine Forecast by Type (2018-2025)
Figure Global Epinephrine Forecast by Application (2018-2025)
Figure Global Epinephrine Market Share Forecast by Application (2018-2025)
Figure Global Epinephrine Forecast by Application (2018-2025)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|